Keywords
Last Name
Institution
Children's Mercy Kansas City
More Search Options
Menu
Home
Find People
Find Everything
About This Site
Annual Report
Export RDF
A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
Biography
contributor
Co-PI
Overview
sponsor award id
3UM1AI068614
Time
start date
2020-07-01
end date
2022-06-30